Skip to main content

Worse Outcomes Seen for Seniors With Alzheimer Disease, Dementia, Polypharmacy

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 21, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, Nov. 21, 2024 -- Older adults with both Alzheimer disease and related dementias (ADRD) and polypharmacy (PPY) can experience more symptoms and have negative health outcomes and physical function decline, according to a study published online Oct. 8 in Biological Research for Nursing.

Martha C. Coates, Ph.D., R.N., from Drexel University in Philadelphia, and colleagues compared the number of symptoms experienced over time in older adults with and without ADRD by PPY status using longitudinal data from the National Health and Aging Trends Study. The sample of Medicare beneficiaries was categorized as neither ADRD nor PPY (1,048 participants), PPY only (761), ADRD only (116), and both ADRD and PPY (127).

The researchers found that on average, participants with both ADRD and PPY experienced more symptoms and had increased odds of falls, hospitalizations, and mortality compared with other groups. Lower physical function was seen for older adults with both ADRD and PPY, and these individuals needed more assistance with activities of daily living and had higher assistive device utilization compared with the other groups.

"Avoiding adverse outcomes related to polypharmacy can improve quality of life and prevent excess disability for older adults with Alzheimer disease and related dementias," Coates said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted November 2024

Read this next

High Midlife Cortisol Tied to Later Risk for Alzheimer Disease in Postmenopausal Women

THURSDAY, May 29, 2025 -- Postmenopausal women with high midlife cortisol have an increased risk for Alzheimer disease (AD), according to a study published online April 24...

2015 to 2021 Saw Decrease in Incidence of Dementia

FRIDAY, May 23, 2025 -- From 2015 to 2021, there was a decrease in the incidence of dementia, but an increase in prevalence, according to a study published online May 20 in The...

Herpes Simplex Virus Type 1 May Affect Risk for Alzheimer Disease

THURSDAY, May 22, 2025 -- Herpes simplex virus type 1 (HSV-1) is associated with an increased risk for Alzheimer disease (AD) based on real-world data from the United States...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.